MYGN MYRIAD GENETICS INCcompanySEC Filings & Insider Trading Activity 2026
Latest MYRIAD GENETICS INC (MYGN) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on May 6, 2026, an 8-K current report filed on July 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for MYRIAD GENETICS INC (MYGN) (SEC CIK 899923), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on MYRIAD GENETICS INC
Ask AI about MYGN filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting MYGN positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on MYGN.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of MYRIAD GENETICS INC (MYGN) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 30, 2026 | - | - | - |
8-K | Jun 23, 2026 | - | - | - |
8-K | Jun 4, 2026 | - | - | |
10-Q | May 6, 2026 | Mar 31, 2026 | - | |
8-K | May 5, 2026 | - | - | - |
10-K | Feb 24, 2026 | Dec 31, 2025 | - | |
8-K | Feb 23, 2026 | - | Analysis | - |
8-K | Jan 12, 2026 | - | - | |
10-Q | Nov 4, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | - | |
10-Q | May 7, 2025 | Mar 31, 2025 | - | |
10-K | Feb 28, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 8, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | - | |
10-Q | May 8, 2024 | Mar 31, 2024 | - | |
SC 13G | May 1, 2024 | - | - | |
SC 13G | Apr 25, 2024 | - | - | |
SC 13G | Mar 18, 2024 | - | - | |
10-K | Feb 28, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | - | |
SC 13G | Oct 17, 2023 | - | - | |
10-Q | Aug 4, 2023 | Jun 30, 2023 | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
SC 13G | Mar 1, 2023 | - | - | |
10-K | Mar 1, 2023 | Dec 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate MYGN share value held by 13F filers tracked by SignalX, by quarter.
- Two Sigma Investments+368.9K (+40%)
- Prudential Financial+275.9K (+262%)
- Goldman Sachs Group+205.8K (+10%)
- Citadel Advisors LLC+200.7K (+69%)
- FMR LLC (Fidelity)+94.3K (+19%)
- BlackRock6.41M (-42%)
- State Street Corp1.54M (-26%)
- Dimensional Fund Advisors548.4K (-43%)
- Morgan Stanley439.0K (-12%)
- Bank of America Corp344.1K (-40%)
- Franklin Resources+106.3K
- Vanguard Group Inc−8.23M
- Invesco Ltd−507.2K
- Principal Financial Group−444.1K
- JPMorgan Chase & Co−380.1K
Source: 13F-HR filings on SEC EDGAR (aggregated from 186 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest MYGN SEC filings in 2026?
MYRIAD GENETICS INC (MYGN) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on May 6, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did MYGN file its most recent 10-K annual report?
MYRIAD GENETICS INC (MYGN) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view MYGN 10-Q quarterly reports?
MYRIAD GENETICS INC (MYGN)'s most recent 10-Q quarterly report was filed on May 6, 2026. SignalX displays every MYGN 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has MYGN filed recently?
MYRIAD GENETICS INC (MYGN)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find MYGN insider trading activity (Form 4)?
SignalX aggregates every MYGN Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does MYGN file with the SEC?
MYRIAD GENETICS INC (MYGN) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new MYGN filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for MYRIAD GENETICS INC (MYGN).
What is MYGN's SEC CIK number?
MYRIAD GENETICS INC (MYGN)'s SEC CIK (Central Index Key) number is 899923. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 899923 to look up all MYGN filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of MYRIAD GENETICS INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 75+ filings.